Skip to main content
Caplight Logo









Urologic Health Inc.

Urologic Health Inc.

Private
Jersey City, New JerseyHealthcare & Life Scienceshttps://urologic.health/

Last Round

Seed

May 14, 2026

Total Funding Raised

$11M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Urologic Health Inc. is a medical device company developing non-invasive diagnostic technology for bladder function assessment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

medical devicenon-invasive urodynamicsurodynamicscatheter-free testingbladder function assessmenturology diagnosticsMedTechAI diagnosticsbladder monitoringmedical sensorsoveractive bladderincontinencebenign prostatic hyperplasiaBPHlongitudinal monitoringFDA 510(k)

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Urologic Health Inc. Comparables

Compare Urologic Health Inc. with similar companies based on industry and business-model similarity.

Urologic Health Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bright Uro
81%
SRS Medical
74%
The Prometheus Group
73%

Urologic Health Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 14, 2026

Key People

Founding team and executive leadership

Noam Omer

Co-Founder, CTO

Founding Team

Adam Yaacov

Co-Founder And CEO

Founding Team

Urologic Health Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    $11M raised from Edge Medical Ventures and others.

  • Feb 10, 2026

    Grew 150% QoQ, from 2 to 5 employees.

Urologic Health Inc. Filings

Explore SEC and related filing metadata, where available.

Urologic Health Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Urologic Health Inc.'s valuation, stock price, and market status.

Is Urologic Health Inc. a public or private company?

Urologic Health Inc. is a private company.

What is the current stock price of Urologic Health Inc.?

Urologic Health Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Urologic Health Inc. worth (valuation)?

Valuation information for Urologic Health Inc. is not publicly available.

Can I buy Urologic Health Inc. stock?

Urologic Health Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Urologic Health Inc.'s last funding round?

Urologic Health Inc.'s most recent funding round was Seed on May 15, 2026.

Who are the main investors in Urologic Health Inc.?

Key investors in Urologic Health Inc. include Scientific Health Development, Edge Medical Ventures, Longevity Venture Partners, MEDX Xelerator LP.

Will Urologic Health Inc. IPO soon?

No public IPO plans have been announced for Urologic Health Inc..

How can I track Urologic Health Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Urologic Health Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJersey City, New Jersey
Employee Range6
Year FoundedN/A
Last FundingMay 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?